Cost-Effectiveness Analysis Of Ticagrelor In Treating Patients With Acute Coronary Syndrome In Hong Kong

This study aimed to evaluate the long-term cost-effectiveness of ticagrelor in ACS patients in Hong Kong (HK) from a public hospital’s perspective.

Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: D.B.C. Wu, B.S.C. Lee, K.K.C. Lee Source Type: research